Therapeutic Asset Ratings
472 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Dabigatran
Atrial Fibrillation
Pfizer
P4
BBB
(79)
WARFARIN
Atrial Fibrillation
Pfizer
P4
BBB
(77)
Crizotinib
Recurrent Childhood Anaplastic Large Cell Lymphoma
Pfizer
P4
BBB
(75)
Rimegepant
Migraine
Pfizer
P4
BBB
(75)
Enzalutamide
Recurrent Prostate Carcinoma
Pfizer
P4
BBB
(73)
MIDAZOLAM
Diabetes Mellitus Type 2
Pfizer
P4
BBB
(73)
DESVENLAFAXINE
Major Depressive Disorder
Pfizer
P4
BBB
(72)
Cyclophosphamide
Lung Non-Small Cell Squamous Carcinoma
Pfizer
P3
BBB
(72)
PREDNISONE TABLETS
Recurrent Non-small Cell Lung Cancer
Pfizer
P3
BB
(71)
Irinotecan
Metastatic Urothelial Carcinoma
Pfizer
P3
BB
(70)
Sigvotatug Vedotin
Carcinoma, Non-Small Cell Lung
Pfizer
P3
BB
(70)
(+)-VINCRISTINE
Metastatic Urothelial Carcinoma
Pfizer
P3
BB
(70)
Crizotinib
IMT
Pfizer
P4
BB
(69)
Dacomitinib
NSCLC
Pfizer
P4
BB
(69)
fx-1006a
Transthyretin Amyloid Cardiomyopathy
Pfizer
P4
BB
(69)
Rimegepant
Phonophobia
Pfizer
P4
BB
(69)
Rimegepant
Photophobia
Pfizer
P4
BB
(69)
Trumenba
Meningococcal Vaccine
Pfizer
P4
BB
(69)
Axitinib
Kidney Neoplasms
Pfizer
P3
BB
(69)
Ponsegromab
Cachexia
Pfizer
P2/3
BB
(69)
7-((3-CHLORO-6,11-DIHYDRO-6-METHYLDIBENZO(C,F)(1,2)THIAZEPIN-11-YL)AMINO)HEPTANOIC ACID S,S-DIOXIDE
Major Depression
Pfizer
P4
BB
(68)
FLUOROURACILUM
Breast Cancer
Pfizer
P4
BB
(68)
Ipilimumab
Kidney Neoplasms
Pfizer
P4
BB
(68)
Irinotecan
Breast Cancer
Pfizer
P4
BB
(67)
Rosuvastatin
Diabetes Mellitus, Type 2
Pfizer
P4
BB
(67)
Showing 1 to 25 of 472 assets
Previous
Page 1 of 19
Next
